For months on end, Neuralstem has been pounding the table for the FDA to give the go-ahead for its phase II ALS trial.
http://seekingalpha.com/article/1439701-neuralstem-rounding-second-with-phase-ii-als-trial?source=feed
http://seekingalpha.com/article/1439701-neuralstem-rounding-second-with-phase-ii-als-trial?source=feed
No comments:
Post a Comment